Effects of interleukins 2 and 12 on TBT-induced alterations of MAP kinases p38 and p44/42 in human natural killer cells

Journal of Applied Toxicology

Volumn 26, Issue 2, 2006, Pages 132-138

  Aluoch, Aloice O ^a   Whalen, Margaret M ^a  

^a TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Human NK cells; Interleukin 12; Interleukin 2; MAP kinases; Tributyltin

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P42; PROTEIN P44; SYNAPTOPHYSIN; TRIBUTYLTIN;

ARTICLE; CELL FUNCTION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TIME SERIES ANALYSIS;

ADULT; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL SEPARATION; CELL SURVIVAL; CULTURE MEDIA; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TRIALKYLTIN COMPOUNDS;

EID: 33645284171     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1116     Document Type: Article

References (37)

1. Abrams SI, Brahmi Z. 1988. Target cell directed NK inactivation. J. Immunol. 140: 2090-2095.
2. Aluoch A, Whalen M. 2005. Tributyltin-induced effects on MAP kinases p38 and p44/42 in human natural killer cells. Toxicology 209: 263-277.
3. Baaijens PA. 1987. Health effect screening and biological monitoring for workers in organotins industries. In Toxicology and Analytics of Tributyltins: The Present Status. Proceedings of an ORTEPA Workshop, Berlin, 15-16 May 1986. ORTEP-Association: Vlissingen-Oost, The Netherlands, 191-208.
4. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpes virus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
5. Chini CCS, Boos MD, Dick CJ, Schoon RA, Leibson PJ. 2000. Regulation of p38 mitogen-activated protein kinase during NK cell activation. Eur. J. Immunol. 30: 2791-2798.
6. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET. 1995. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perform and granzyme gene expression in fresh human NK cells. Cell. Immunol. 165: 33-43.
7. Djeu JY, Jiang K, Wei S. 2002. A view to a kill: signals triggering cytotoxicity. Clin. Cancer Res. 8: 636-640.
8. Fleisher G, Starr S, Koven N, Kamiya H, Douglas SD, Henle W. 1982. A non-X-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J. Pediatr. 100: 727-730.
9. Gately MK, Renzetti LM, Magram J, Stem AS, Adorini L, Gubbler U, Presky DH. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16: 495-521.
10. Ghoneum M, Hussein AE, Gill G, Alfred LJ. 1990. Suppression of murine natural killer cell activity by tributyltin: in vivo and in vitro assessment. Environ. Res. 52: 178-186.
11. Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, Djeu JY. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1: 419-425.
12. Kannan K, Falandyz J. 1997. Butyltin residues in sediment, fish, fish-eating birds, harbour porpoise and human tissues from the Polish coast of the Baltic Sea. Mar. Pollut. Bull. 34: 203-207.
13. Kannan K, Senthilkumar K, Giesy JP. 1999. Occurrence of butyltin compounds in human blood. Environ. Sci. Technol. 33: 1776-1779.
14. Kannan K, Tanabe S, Tatsukawa R. 1995. Occurrence of butyltin residues in certain foodstuffs. Bull. Environ. Contam. Toxicol. 55: 510-516.
15. Kimbrough RD. 1976. Toxicity and health effects of selected organotins compounds: A review. Environ. Health Perspect. 14: 51-56.
16. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845.
17. Lafont V, Loisel S, Liautard J, Dudal S, Sable-Teychene M, Liautard JP, Favero J. 2003. Specific signaling pathways triggered by IL-2 in human Vγ9Vδ2 T cells: An amalgamation of NK and αβ T cell signaling. J. Immunol. 171: 5225-5232.
18. Loganathan BG, Kannan K, Owen DA, Sajwan KS. 2000. Butyltin compounds in freshwater ecosystems. In Persistent, Bioaccumulative, and Toxic Chemicals I: Fate and Exposure, Lipnick RL, Hermens J, Jones K, Muir D (eds). Am. Chem. Soc. Pub. Oxford University Press: London.
19. Lotzova E. 1993. Definition and function of natural killer cells. Nat. Immun. 12: 169-176.
20. Moretta L, Biassoni R, Mingari MC, Morerra A. 2002. Natural killer cells: A mystery no more. Scand. J. Immunol. 55: 229-232.
21. Morgan DA, Ruscetti FW, Gallo R. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrow. Science 193: 1007-1008.
22. Ramoni C, Luciani F, Spadaro F, Lugini L, Lozupone F, Fais S. 2002. Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. Eur. J. Immunol. 32: 3059-3065.
23. Robinson MJ, Cobb MH. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol. 9: 180-186.
24. Smialowicz RJ. 2002. The rat as a model in developmental immunotoxicology. Hum. Exp. Toxicol. 21: 513-519.
25. Smith KA. 1988. Interleukin-2 inception, impact, and implications. Science 240: 1169-1176.
26. Su B, Karin M. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8: 402-411.
27. Tanabe S, Prudente M, Mizuno T, Hasegawa J. Iwata H, Miyazaki N. 1998. Butyltin contamination in marine mammals from north Pacific and Asian coastal waters. Environ. Sci. Technol. 32: 193-198.
28. Trinchieri G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
29. Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr L, Perussia B. 1998. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. J. Immunol. 161: 6648-6656.
30. Visconti R, Gadina M, Chiariello M, Chen EH, Stancato LF, Gutkind JS, O'Shea JJ. 2000. Importance of the MKK6/p38 pathway for interleukin 12-induced STAT4 serine phosphorylation and transcription activity. Blood 96: 1844-1852.
31. Whalen MM, Green SA, Longanathan BG. 2002a. Brief butyltin exposure induces irreversible inhibition of the cytotoxic function on human natural killer cells, in vitro. Environ. Res. 88: 19-29.
32. Whalen MM, Loganathan BG, Kannan K. 1999. Immunotoxicity of environmentally relevant concentrations of butyltins on human natural killer cells in vitro. Environ. Res. 81: 108-116.
33. Whalen MM, Williams TB, Green SA, Longanathan BG. 2002b. Interleukins 2 and 12 produce recovery of cytotoxic function in tributyltin-exposed human natural killer cells. Environ. Res. 88: 199-209.
34. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perussia B. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146: 3074-3081.
35. World Health Organization (WHO)/Food and Agriculture Organization of the United Nations (FAO). 1984. Data Sheet on Pesticides No. 65: Bis (trihutyltin) Oxide VBC/PDS/DS/85.65. World Health Organization: Geneva.
36. Xiao J, Brahmi Z. 1989. Target cell-directed inactivation and IL-2 dependent reactivation of LAK cell. Cell. Immunol. 122: 295-306.
37. Yu TK, Caudell EG, Smid C, Grimm E. 2000. IL-2 activation of NK cell: involvement of MKK1/2/ERK but not p38 kinase pathway. J. Immunol. 164: 6244-6251.